Knoll Capital Management as of March 31, 2015
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 17 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Medivation | 82.6 | $284M | 2.2M | 129.07 | |
| Ampio Pharmaceuticals | 7.4 | $26M | 3.4M | 7.53 | |
| Synthetic Biologics | 2.2 | $7.4M | 3.4M | 2.19 | |
| Alcobra | 1.8 | $6.3M | 1.1M | 5.63 | |
| Newlink Genetics Corporation | 1.6 | $5.6M | 102k | 54.71 | |
| Advaxis | 1.2 | $4.0M | 275k | 14.44 | |
| Keryx Biopharmaceuticals | 0.7 | $2.5M | 200k | 12.73 | |
| Bio Blast Pharma | 0.6 | $2.0M | 338k | 6.00 | |
| Aldeyra Therapeutics (ALDX) | 0.4 | $1.4M | 136k | 10.18 | |
| Lion Biotechnologies | 0.3 | $1.2M | 100k | 12.11 | |
| Advaxis | 0.3 | $1.2M | 113k | 10.40 | |
| Plasmatech Biopharmaceutical | 0.2 | $669k | 213k | 3.14 | |
| Galmed Pharmaceuticals | 0.2 | $612k | 65k | 9.42 | |
| Ohr Pharmaceutical | 0.1 | $521k | 205k | 2.54 | |
| Evoke Pharma | 0.1 | $380k | 54k | 7.06 | |
| Zosano Pharma | 0.1 | $202k | 20k | 10.10 | |
| Aptose Biosciences | 0.0 | $108k | 20k | 5.40 |
